IBBQ vs. CNCR

Last updated Jun 4, 2026

IBBQ (Invesco Nasdaq Biotechnology ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - IBBQ tracks the NASDAQ / Biotechnology while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. IBBQ charges 0.00%/yr vs 0.79%/yr for CNCR.

Performance

IBBQ vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Nasdaq Biotechnology ETF (IBBQ) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IBBQ

• 1D: 1.77%
• 1M: -1.63%
• YTD: 1.91%
• 6M: 0.94%
• 1Y: 39.72%
• 3Y*: 12.60%
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IBBQ vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
IBBQ Invesco Nasdaq Biotechnology ETF	-2.53%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

IBBQ vs. CNCR - Sectors Allocation Comparison

Sectors	IBBQ	CNCR
Healthcare	98.3%	96.6%
Financial Services	0.0%	3.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

IBBQ vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBBQ

IBBQ Risk / Return Rank: 67
IBBQ Sharpe Ratio Rank: 59
IBBQ Sortino Ratio Rank: 60
IBBQ Omega Ratio Rank: 54
IBBQ Calmar Ratio Rank: 85
IBBQ Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBBQ vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotechnology ETF (IBBQ) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IBBQ	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	2.03	—	—
Sortino ratio: Return per unit of downside risk	2.86	—	—
Omega ratio: Gain probability vs. loss probability	1.34	—	—
Calmar ratio: Return relative to maximum drawdown	4.79	—	—
Martin ratio: Return relative to average drawdown	15.68	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	IBBQ	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.03	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	—	—

Drawdowns

IBBQ vs. CNCR - Drawdown Comparison

The maximum IBBQ drawdown since its inception was -37.94%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for IBBQ and CNCR.

Drawdown Indicators

	IBBQ	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-37.94%	0.00%	-37.94%
Max Drawdown (1Y) Largest decline over 1 year	-8.34%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-23.66%	—	—
Current Drawdown Current decline from peak	-5.17%	0.00%	-5.17%
Average Drawdown Average peak-to-trough decline	-16.82%	0.00%	-16.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.54%	—	—

Volatility

Volatility by Period

	IBBQ	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.84%	—	—
Volatility (6M) Calculated over the trailing 6-month period	15.14%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	19.63%	0.00%	+19.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.86%	0.00%	+21.86%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.86%	0.00%	+21.86%

IBBQ vs. CNCR - Expense Ratio Comparison

IBBQ has a 0.00% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

IBBQ vs. CNCR - Dividend Comparison

IBBQ's dividend yield for the trailing twelve months is around 0.87%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IBBQ Invesco Nasdaq Biotechnology ETF	0.87%	0.90%	1.14%	0.81%	0.76%	0.63%

Frequently Asked Questions

Which ETF is better, IBBQ or CNCR?

On fees, IBBQ is cheaper at 0.00% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, IBBQ or CNCR?

IBBQ is cheaper with a 0.00% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, IBBQ or CNCR?

IBBQ has the higher dividend yield at 0.87%, compared with 0.00% for CNCR.

What is the main difference between IBBQ and CNCR?

IBBQ tracks NASDAQ / Biotechnology, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Invesco and Exchange Traded Concepts. Their fees differ too: 0.00% for IBBQ and 0.79% for CNCR.